| Literature DB >> 30377670 |
Xiaofei Feng1, Kangxian Li1, Fangming Tan1, Mei Zhu1, Jieyi Zhou1, Yongjun Lai1, Lingfeng Zeng1, Yingting Ye1, Jing Huang1, Xiaosong Wu1, Shasha Li1.
Abstract
OBJECTIVE: The objective of the present study was to investigate the hepatoprotective role of Radix Fici Hirtae on acute alcohol-induced liver injury in mice.Entities:
Keywords: Alcohol-induced liver injury; Hepatoprotective; Radix Fici Hirtae
Year: 2018 PMID: 30377670 PMCID: PMC6202661 DOI: 10.1016/j.bbrep.2018.10.003
Source DB: PubMed Journal: Biochem Biophys Rep ISSN: 2405-5808
Fig. 1Changes in hepatic pathology (HE×400). Note: M-G:model group, N-G:normal control group, H-PE:high dose group of petroleum ether, M-PE:middle dose group of petroleum ether, L-PE:low dose group of petroleum ether, H-CL:high dose group of chloroform, M-CL:middle dose group of chloroform, L-CL:low dose group of chloroform, H-EA:high dose group of ethyl acetate, M-EA:middle dose group of ethyl acetate, L-EA:low dose group of ethyl acetate, H-nB:high dose group of saturated n-butyl alcohol, M-nB:middle dose group of saturated n-butyl alcohol, L-nB:low dose group of saturated n-butyl alcohol, H-RW:high dose group of residual aqueous solution, M-RW:middle dose group of residual aqueous solution, L-RW:low dose group of residual aqueous solution.
Change of indexes of the serum in each dose group (n = 6).
| Group | AST(U/L) | ALT(U/L) | AKP(king U/100 mL) | LDH(U/L) |
|---|---|---|---|---|
| M-G | 36.45 ± 7.29 | 18.27 ± 2.23 | 34.39 ± 2.20 | 1930.72 ± 473.45 |
| N-G | 19.41 ± 2.73* | 13.94 ± 3.33 | 27.42 ± 3.59* | 1016.97 ± 279.19* |
| H-PE | 26.04 ± 0.91* | 13.43 ± 2.43 | 18.52 ± 2.56* | 1328.11 ± 349.25* |
| M-PE | 31.59 ± 3.74 | 21.74 ± 4.52 | 29.01 ± 1.95 | 1040.95 ± 239.50* |
| L-PE | 38.74 ± 5.05 | 26.99 ± 2.64 | 32.19 ± 6.75 | 1448.07 ± 111.04* |
| H-CL | 27.14 ± 3.17* | 4.3 ± 1.14* | 21.92 ± 2.50* | 531.65 ± 111.86* |
| M -CL | 27.38 ± 5.79* | 4.74 ± 1.64* | 23.24 ± 4.17* | 782.85 ± 124.86* |
| L-CL | 28.47 ± 2.56* | 9.03 ± 2.29* | 22.3 ± 4.88* | 1953.38 ± 175.64 |
| H-EA | 22.73 ± 4.06* | 9.42 ± 2.69* | 23.81 ± 4.67* | 868.47 ± 249.40* |
| M-EA | 26.82 ± 6.25* | 11.82 ± 1.85* | 21.75 ± 5.55* | 1311.63 ± 222.15* |
| L-EA | 39.11 ± 6.00 | 15.88 ± 2.03 | 32.94 ± 7.18 | 1616.64 ± 325.62 |
| H-n-B | 27.95 ± 3.57* | 13.55 ± 3.65 | 23.41 ± 2.25* | 434.49 ± 44.57* |
| M-n-B | 28.57 ± 4.41* | 20.68 ± 4.99 | 27.31 ± 5.40* | 915.99 ± 196.68* |
| L-n-B | 26.46 ± 5.54* | 22.17 ± 3.84 | 23.28 ± 2.83* | 1462.64 ± 276.39* |
| H-RW | 24.99 ± 2.83* | 11.23 ± 4.25* | 24.66 ± 3.90* | 646.98 ± 167.60* |
| M-RW | 27.91 ± 6.62* | 20.24 ± 3.30 | 23.54 ± 4.14* | 599.21 ± 97.18* |
| L-RW | 27.70 ± 3.81* | 28.82 ± 6.51 | 20.95 ± 5.00* | 857.51 ± 210.07* |
Fig. 2Change in AST and ALT levels in different groups.
Fig. 3Change in AKP levels in different groups.
Fig. 4Change in LDH levels in different groups.